Ebix Declares 7.5 Cent Quarterly Dividend, Payable June 16, 2020, to Shareholders of Record June 2, 2020
JOHNS CREEK, Ga., May 21, 2020 (GLOBE NEWSWIRE) — Ebix, Inc., (NASDAQ: EBIX) a leading international supplier of On-Demand software […]
InflaRx Reports Q1 2020 Financial & Operating Results
End of Phase II meeting with the FDA scheduled to discuss the path forward for IFX-1 in Hidradenitis SuppurativaInitial promising […]
Flexion Therapeutics Announces Pricing of Public Offering of Common Stock
BURLINGTON, Mass., May 21, 2020 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced the pricing of an underwritten public […]
Matrix Service Awarded EPC of LNG Peak Shaving Facility
TULSA, Okla., May 21, 2020 (GLOBE NEWSWIRE) — Matrix Service Company (Nasdaq: MTRX) (“Matrix” or “the Company”), a leading contractor […]
Fulcrum Therapeutics Announces Multiple Presentations at the 2020 American Academy of Neurology (AAN) Science Highlights Virtual Platform
CAMBRIDGE, Mass., May 21, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives […]
Anavex Life Sciences Announces Initiation of First-in-Human Phase 1 Study of ANAVEX®3-71 (AF710B)
NEW YORK, May 21, 2020 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]
Apollo Investment Corporation Reports Financial Results for the Quarter and Fiscal Year Ended March 31, 2020
Fiscal Fourth Quarter and Other Recent Highlights:Net investment income per share for the quarter was $0.59 compared to $0.54 for […]
Educational Development Corporation Announces Fiscal Fourth Quarter, Fiscal 2020 Results and Provides First Quarter Fiscal 2021 Revenue Guidance
TULSA, Okla., May 21, 2020 (GLOBE NEWSWIRE) — Educational Development Corporation (“EDC”, or the “Company”) (NASDAQ: EDUC) (http://www.edcpub.com) today reports […]
Apellis Announces Plans to Submit NDA for Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH)
Submission of New Drug ApplicationBay Street News
European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Roxadustat
TOKYO and SAN FRANCISCO, May 21, 2020 (GLOBE NEWSWIRE) — Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, […]
